Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Budget Request Proposes New User Fees For Reinspection Of Manufacturing Facilities

This article was originally published in The Pink Sheet Daily

Executive Summary

The agency also plans to increase drug safety and to fund the Critical Path initiative for the first time.

You may also be interested in...



Generic Drug User Fees Would Fund Faster ANDA Approvals Under FDA Budget

Agency’s $2.1 billion FY ’08 budget request also asks for more money for drug safety surveillance and assessment.

Generic Drug User Fees Would Fund Faster ANDA Approvals Under FDA Budget

Agency’s $2.1 billion FY ’08 budget request also asks for more money for drug safety surveillance and assessment.

FDA Alliance Forms With Goal Of Boosting Agency Appropriations

Advocacy and education organization has ambitious plan to build membership and present an “alternative budget” by June.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel